メインメニューをとばして、このページの本文エリアへ

今週の一面

10月13日号 本庶佑さん ノーベル医学生理学賞を受賞

音声を聞いてみよう

WORDS 単語をチェック

achievement
偉業
distinguished professor
特別教授
physiology
生理学
medicine
医学
protein
たんぱく質
immunotherapeutic
免疫療法の(後出 immune system は免疫系、immune response は免疫反応、immunity は免疫力)
cancer
がん(後出 anti-cancer drug は抗がん剤)
treatment
治療(後出 therapy も同意)
appreciate
高く評価する
regulate
制御する
unleash ~ on ...
(ここでは)~の抑制を解いて…を攻撃させる
tumor
(ここでは悪性)腫瘍
disable
無力化する
award ceremony
授賞式
gratitude
感謝、謝意
co- ~
共同の~
clinically
臨床的に
apply
適用する
significance
意味
cell
細胞
lymphocyte
リンパ球
enhance
高める
pharmaceutical
製薬の
inhibitor
反応抑制剤
trade name
商品名

Nobel Achievement   

Honjo Tasuku, distinguished professor at Kyoto University, has won the 2018 Nobel Prize in physiology and medicine for his discovery of a protein that helped lead to immunotherapeutic methods of cancer treatment, the Karolinska Institute in Sweden announced on Oct. 1.

The prize will be presented to Honjo, 76, and James Allison, 70, professor at the University of Texas.

The Karolinska Institute appreciated Honjo's discovery of PD-1 - a type of protein that regulates immune system function - which led to the development of cancer therapies unleashing the immune system on tumors by disabling the protein's function.

Honjo is the first Japanese national to win a Nobel Prize in two years and the 26th overall. The award ceremony is scheduled to be held in Stockholm on Dec. 10, and a total of 9 million Swedish kronur, or approximately 115 million yen, in prize money will be presented to Honjo and Allison.

At a news conference, Honjo expressed joy at winning the award. "It's an honor to win such a great prize. I'd like to express my gratitude to many people, including my co-researchers, students, those who supported our research, and my family," he said.

He said he is happy that the results of his research are being clinically applied and saving the lives of patients with serious cancers. "When I'm thanked by patients who recover, I truly feel the significance of our research," he commented.

In 1992, a research team led by Honjo found the PD-1 protein in T cells, a kind of lymphocyte that controls the immune system, and confirmed the protein regulates immune response. The team thought that if this function was disabled, it would enhance immunity and could be applied to fight cancer.

The development of anti-cancer drugs progressed based on this discovery. In September 2014, Ono Pharmaceutical Co. released a PD-1 inhibitor drug under the trade name "Opdivo."

[本文 - 310 words]

週刊英語学習紙 毎日ウィークリー

毎日新聞のアカウント

話題の記事

アクセスランキング

毎時01分更新

  1. 大坂なおみ選手の肌白く表現 日清食品が謝罪と米英紙
  2. 大坂なおみ、世界ランク1位の条件 WTA公式サイトが伝える
  3. 誤って高圧幹線を切断 大阪・高槻で病院など停電
  4. コート内外のギャップも魅力 大坂なおみ、全豪4強
  5. 女子中学生が意識不明 殺人未遂容疑で母親を逮捕 前橋